Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM.

Eur Respir J. 2018 Nov 8. pii: 1801687. doi: 10.1183/13993003.01687-2018. [Epub ahead of print] No abstract available.

PMID:
30409820
2.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
3.

Key topics in pulmonary vascular diseases (assembly 13) from the European Respiratory Society 2018 Parisian Congress.

Ramjug S, Noordegraaf AV, Delcroix M.

J Thorac Dis. 2018 Sep;10(Suppl 25):S3029-S3033. doi: 10.21037/jtd.2018.09.07. No abstract available.

4.

Impaired Cardiac Reserve and Abnormal Vascular Load Limit Exercise Capacity in Chronic Thromboembolic Disease.

Claeys M, Claessen G, La Gerche A, Petit T, Belge C, Meyns B, Bogaert J, Willems R, Claus P, Delcroix M.

JACC Cardiovasc Imaging. 2018 Sep 6. pii: S1936-878X(18)30680-6. doi: 10.1016/j.jcmg.2018.07.021. [Epub ahead of print]

PMID:
30219401
5.

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism.

Klok FA, Delcroix M, Bogaard HJ.

J Thromb Haemost. 2018 Jun;16(6):1040-1051. doi: 10.1111/jth.14016. Epub 2018 May 8. Review.

PMID:
29608809
6.

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.

Souza R, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Torbicki A, Rubin LJ, Simonneau G.

PLoS One. 2018 Mar 28;13(3):e0193226. doi: 10.1371/journal.pone.0193226. eCollection 2018.

7.

Hypocalcemia after Denosumab in a Pulmonary Hypertension Patient Receiving Epoprostenol.

De Muynck B, Leys M, Cuypers J, Vanderschueren D, Delcroix M, Belge C.

Respiration. 2018;95(2):139-142. doi: 10.1159/000481713. Epub 2017 Oct 30.

PMID:
29485420
8.

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.

McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N.

J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.

9.

Macitentan in pulmonary hypertension due to left ventricular dysfunction.

Vachiéry JL, Delcroix M, Al-Hiti H, Efficace M, Hutyra M, Lack G, Papadakis K, Rubin LJ.

Eur Respir J. 2018 Feb 7;51(2). pii: 1701886. doi: 10.1183/13993003.01886-2017. Print 2018 Feb.

PMID:
29437943
10.

Postoperative left ventricular function in different types of pulmonary hypertension: a comparative study.

Verbelen T, Van De Bruaene A, Cools B, Van Raemdonck D, Delcroix M, Rega F, Meyns B.

Interact Cardiovasc Thorac Surg. 2018 May 1;26(5):813-819. doi: 10.1093/icvts/ivx418.

PMID:
29300906
11.

Atrial volume and function during exercise in health and disease.

Schnell F, Claessen G, La Gerche A, Claus P, Bogaert J, Delcroix M, Carré F, Heidbuchel H.

J Cardiovasc Magn Reson. 2017 Dec 18;19(1):104. doi: 10.1186/s12968-017-0416-9.

12.

Low-flow support of the chronic pressure-overloaded right ventricle induces reversed remodeling.

Verbelen T, Claus P, Burkhoff D, Driesen RB, Kadur Nagaraju C, Verbeken E, Sipido K, Delcroix M, Rega F, Meyns B.

J Heart Lung Transplant. 2018 Jan;37(1):151-160. doi: 10.1016/j.healun.2017.09.014. Epub 2017 Sep 29.

PMID:
29056459
13.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug.

PMID:
28775047
14.

Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy.

Van Dievel J, Sciot R, Delcroix M, Vandeweyer RO, Debiec-Rychter M, Dewaele B, Cornillie J, Van Cann T, Meyns B, Schöffski P.

Oncol Res Treat. 2017;40(6):353-359. doi: 10.1159/000476036. Epub 2017 May 12.

15.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani HA, Le Brun FO, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A.

Eur Heart J. 2017 Apr 14;38(15):1147-1155. doi: 10.1093/eurheartj/ehx025.

16.

Diagnosis of chronic thromboembolic pulmonary hypertension.

Gopalan D, Delcroix M, Held M.

Eur Respir Rev. 2017 Mar 15;26(143). pii: 160108. doi: 10.1183/16000617.0108-2016. Print 2017 Jan. Review.

17.

Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.

Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, Huisman MV, Klok FA.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601792. doi: 10.1183/13993003.01792-2016. Print 2017 Feb.

18.

Systolic and diastolic unloading by mechanical support of the acute vs the chronic pressure overloaded right ventricle.

Verbelen T, Burkhoff D, Kasama K, Delcroix M, Rega F, Meyns B.

J Heart Lung Transplant. 2017 Apr;36(4):457-465. doi: 10.1016/j.healun.2016.10.003. Epub 2016 Oct 17.

PMID:
27865733
19.

BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.

Vengethasamy L, Hautefort A, Tielemans B, Belge C, Perros F, Verleden S, Fadel E, Van Raemdonck D, Delcroix M, Quarck R.

Pflugers Arch. 2016 Nov;468(11-12):1969-1983. Epub 2016 Nov 6.

PMID:
27816994
20.

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O.

Chest. 2017 Jan;151(1):106-118. doi: 10.1016/j.chest.2016.08.1473. Epub 2016 Sep 23. Erratum in: Chest. 2018 May;153(5):1287.

21.

Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors.

Delcroix M, Kerr K, Fedullo P.

Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S201-6. doi: 10.1513/AnnalsATS.201509-621AS. Review.

PMID:
27571001
22.

Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers.

Claessen G, La Gerche A, Petit T, Gillijns H, Bogaert J, Claeys M, Dymarkowski S, Claus P, Delcroix M, Heidbuchel H.

J Heart Lung Transplant. 2017 Feb;36(2):148-156. doi: 10.1016/j.healun.2016.06.018. Epub 2016 Jun 24.

PMID:
27475894
23.

Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.

Saker M, Lipskaia L, Marcos E, Abid S, Parpaleix A, Houssaini A, Validire P, Girard P, Noureddine H, Boyer L, Vienney N, Amsellem V, Marguerit L, Maitre B, Derumeaux G, Dubois-Rande JL, Jourdan-Lesaux C, Delcroix M, Quarck R, Adnot S.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1879-90. doi: 10.1161/ATVBAHA.116.307839. Epub 2016 Jul 21.

PMID:
27444202
24.

Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.

Parpaleix A, Amsellem V, Houssaini A, Abid S, Breau M, Marcos E, Sawaki D, Delcroix M, Quarck R, Maillard A, Couillin I, Ryffel B, Adnot S.

Eur Respir J. 2016 Aug;48(2):470-83. doi: 10.1183/13993003.01448-2015. Epub 2016 Jul 13.

25.

Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models".

Belge C, Quarck R, Delcroix M.

Circulation. 2016 Apr 5;133(14):e591. doi: 10.1161/CIRCULATIONAHA.115.018683. No abstract available.

PMID:
27045135
26.

Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.

Wan F, Letavernier E, Abid S, Houssaini A, Czibik G, Marcos E, Rideau D, Parpaleix A, Lipskaia L, Amsellem V, Gellen B, Sawaki D, Derumeaux G, Dubois-Randé JL, Delcroix M, Quarck R, Baud L, Adnot S.

Am J Respir Cell Mol Biol. 2016 Sep;55(3):337-51. doi: 10.1165/rcmb.2015-0257OC.

PMID:
26974350
27.

Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population.

Milano M, Moraes MO, Rodenbusch R, Carvalho CX, Delcroix M, Mousquer G, Laux da Costa L, Unis G, Dalla Costa ER, Rossetti ML.

PLoS One. 2016 Feb 3;11(2):e0147814. doi: 10.1371/journal.pone.0147814. eCollection 2016.

28.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.

Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

PMID:
26826181
29.

Pulmonary arterial hypertension: the burden of disease and impact on quality of life.

Delcroix M, Howard L.

Eur Respir Rev. 2015 Dec;24(138):621-9. doi: 10.1183/16000617.0063-2015. Review.

30.

Is Right Ventricular Remodeling in Pulmonary Hypertension Dependent on Etiology? An Echocardiographic Study.

Giusca S, Popa E, Amzulescu MS, Ghiorghiu I, Coman IM, Popescu BA, Delcroix M, Voigt JU, Ginghina C, Jurcut R.

Echocardiography. 2016 Apr;33(4):546-54. doi: 10.1111/echo.13112. Epub 2015 Nov 6.

PMID:
26542101
31.

Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise.

Claessen G, La Gerche A, Voigt JU, Dymarkowski S, Schnell F, Petit T, Willems R, Claus P, Delcroix M, Heidbuchel H.

JACC Cardiovasc Imaging. 2016 May;9(5):532-43. doi: 10.1016/j.jcmg.2015.06.018. Epub 2015 Oct 21.

32.

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN.

Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ.

Eur Respir J. 2015 Dec;46(6):1711-20. doi: 10.1183/13993003.00364-2015. Epub 2015 Oct 22.

33.

Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension.

Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M.

Eur Respir J. 2015 Aug;46(2):431-43. doi: 10.1183/09031936.00009914. Epub 2015 Jun 25.

34.

Mechanical support of the pressure overloaded right ventricle: an acute feasibility study comparing low and high flow support.

Verbelen T, Verhoeven J, Goda M, Burkhoff D, Delcroix M, Rega F, Meyns B.

Am J Physiol Heart Circ Physiol. 2015 Aug 15;309(4):H615-24. doi: 10.1152/ajpheart.00246.2015. Epub 2015 Jun 12.

35.

Apical traction: a novel visual echocardiographic parameter to predict survival in patients with pulmonary hypertension.

Unlu S, Farsalinos K, Ameloot K, Daraban AM, Ciarka A, Delcroix M, Voigt JU.

Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):177-83. doi: 10.1093/ehjci/jev131. Epub 2015 Jun 1.

36.

A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases.

Laux da Costa L, Delcroix M, Dalla Costa ER, Prestes IV, Milano M, Francis SS, Unis G, Silva DR, Riley LW, Rossetti ML.

Tuberculosis (Edinb). 2015 Jul;95(4):421-5. doi: 10.1016/j.tube.2015.04.008. Epub 2015 May 14.

37.

Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy.

Claessen G, La Gerche A, Dymarkowski S, Claus P, Delcroix M, Heidbuchel H.

J Am Heart Assoc. 2015 Mar 23;4(3):e001602. doi: 10.1161/JAHA.114.001602.

38.

[Chronic thromboembolic pulmonary hypertension].

Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:119-29. Turkish.

39.

Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension.

Claessen G, La Gerche A, Wielandts JY, Bogaert J, Van Cleemput J, Wuyts W, Claus P, Delcroix M, Heidbuchel H.

Heart. 2015 Apr;101(8):637-44. doi: 10.1136/heartjnl-2014-306851. Epub 2015 Feb 16.

PMID:
25686630
40.

An extremely high-altitude plume seen at Mars' morning terminator.

Sánchez-Lavega A, Muñoz AG, García-Melendo E, Pérez-Hoyos S, Gómez-Forrellad JM, Pellier C, Delcroix M, López-Valverde MA, González-Galindo F, Jaeschke W, Parker D, Phillips J, Peach D.

Nature. 2015 Feb 26;518(7540):525-8. doi: 10.1038/nature14162. Epub 2015 Feb 16.

PMID:
25686601
41.

In situ quartz crystal microbalance monitoring of the adsorption of polyoxometalate on a polyampholyte polymer matrix.

Raj G, Swalus C, Delcroix M, Devillers M, Dupont-Gillain C, Gaigneaux EM.

J Colloid Interface Sci. 2015 May 1;445:24-30. doi: 10.1016/j.jcis.2014.12.035. Epub 2014 Dec 24.

PMID:
25596365
42.

Role for telomerase in pulmonary hypertension.

Mouraret N, Houssaïni A, Abid S, Quarck R, Marcos E, Parpaleix A, Gary-Bobo G, Dubois-Randé JL, Derumeaux G, Boczkowski J, Delcroix M, Blasco MA, Lipskaia L, Amsellem V, Adnot S.

Circulation. 2015 Feb 24;131(8):742-755. doi: 10.1161/CIRCULATIONAHA.114.013258. Epub 2014 Dec 30.

43.

Clinical significance of dynamic pulmonary vascular resistance in two populations at risk of pulmonary arterial hypertension.

Gabriels C, Lancellotti P, Van De Bruaene A, Voilliot D, De Meester P, Buys R, Delcroix M, Budts W.

Eur Heart J Cardiovasc Imaging. 2015 May;16(5):564-70. doi: 10.1093/ehjci/jeu287. Epub 2014 Dec 18.

44.

Effect of macitentan on hospitalizations: results from the SERAPHIN trial.

Channick RN, Delcroix M, Ghofrani HA, Hunsche E, Jansa P, Le Brun FO, Mehta S, Pulido T, Rubin LJ, Sastry BK, Simonneau G, Sitbon O, Souza R, Torbicki A, Galiè N.

JACC Heart Fail. 2015 Jan;3(1):1-8. doi: 10.1016/j.jchf.2014.07.013. Epub 2014 Nov 11.

45.

Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension?

Quarck R, Delcroix M.

Eur Respir J. 2014 Oct;44(4):842-5. doi: 10.1183/09031936.00120014. No abstract available.

46.

Protein adsorption can be reversibly switched on and off on mixed PEO/PAA brushes.

Delcroix MF, Laurent S, Huet GL, Dupont-Gillain CC.

Acta Biomater. 2015 Jan;11:68-79. doi: 10.1016/j.actbio.2014.09.010. Epub 2014 Sep 16.

PMID:
25234158
47.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
48.

Clinical value of echocardiographic Doppler-derived right ventricular dp/dt in patients with pulmonary arterial hypertension.

Ameloot K, Palmers PJ, Vande Bruaene A, Gerits A, Budts W, Voigt JU, Delcroix M.

Eur Heart J Cardiovasc Imaging. 2014 Dec;15(12):1411-9. doi: 10.1093/ehjci/jeu134. Epub 2014 Sep 8.

PMID:
25201651
49.

A different view on predictors of pulmonary hypertension in secundum atrial septal defect.

Gabriels C, De Meester P, Pasquet A, De Backer J, Paelinck BP, Morissens M, Van De Bruaene A, Delcroix M, Budts W.

Int J Cardiol. 2014 Oct 20;176(3):833-40. doi: 10.1016/j.ijcard.2014.08.009. Epub 2014 Aug 8.

PMID:
25149406
50.

Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Schölzel BE, Post MC, van de Bruaene A, Dymarkowski S, Wuyts W, Meyns B, Budts W, Delcroix M.

Int J Cardiovasc Imaging. 2015 Jan;31(1):143-50. doi: 10.1007/s10554-014-0517-6. Epub 2014 Aug 22.

PMID:
25146554

Supplemental Content

Loading ...
Support Center